Ajanta Pharma - Q2 Result Update

Financial Results with Results Press Release & Limited Review for Sept 30, 2013
Link: Click Here

No words to describe such a result.
Now after so much of surprises from the company time and again, it seems that we should stop considering any targets for this company. From the day, it was mentioned on this blog till today, it has appreciated more than 200%. And I am seriously not sure, how much more upside is left in this counter.

Revenues has jumped from 186 Cr to 280 Cr YoY, which shows a growth of 50%.
Net profit has jumped 22 Cr to 56 Cr YoY, which shows a growth of 155%.
Hence the EPS stands at 15.88 Vs 6.23 YoY, adjusted according to Bonus.
Exports contributed 64% of the total operating income.

Company has filed 3 more ANDAs with US FDA in this quarter, which takes the total ANDA filed to 18, out of which 16 are pending and 2 are approved.

My Views:
I dont think there is any point in setting any targets for Ajanta Pharma now. The stock has continued its outperformance, and this time the results are way above expectations. There were definitely, lots of expectations set by many experts before the results itself, and hence it already appreciated about 20% from last quarter results till yesterday. But since they have declared the results which was above expectations of most of them, the stock, even after so much appreciation since January this year, is again up 10-15% today.
I am still waiting for company to announce updates on 2 new plants coming up in Gujarat. According to news earlier, they were about to start the operations in those plants in FY15 i.e. anytime after Mar 14 till Mar 15.
So for now, I would only say that, those who can wait longer can continue to hold or else, even if you sell few shares at this price, there is nothing wrong in it.
I would take this stock, quarter by quarter, and hence will wait for company to announce next quarter numbers, till then, will continue to hold (Or may be, sell about 20% shares, if needed)